PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: bankruptcy

Practical risk-based guide for managing data integrity

1. ACTIVE PHARMACEUTICAL INGREDIENTS COMMITTEE. Practical risk-based guide for managing data integrity Version 1, March 2019. 2. PREAMBLE. This original version of this guidance document has been compiled by a subdivision of the APIC Data integrity Task Force on behalf of the Active Pharmaceutical Ingredient Committee (APIC) of CEFIC. The Task Force members are: Charles Gibbons, AbbVie, Ireland Danny De Scheemaecker, Janssen Pharmaceutica NV. Rob De Proost, Janssen Pharmaceutica NV. Dieter Vanderlinden, Ajinomoto Omnichem Andr van der Biezen, Aspen Oss Sebastian Fuchs, Tereos Daniel Davies, Lonza AG. Fraser Strachan, DSM. Bjorn Van Krevelen, Janssen Pharmaceutica NV. Alessandro Fava, (Fabbrica Italiana Sintetici) SpA. Alexandra Silva, Hovione FarmaCiencia SA. Nicola Martone, DSM Sinochem Pharmaceuticals Ulrich-Andreas Opitz, Merck KGaA. Dominique Rasewsky, Merck KGaA. With support and review from: Pieter van der Hoeven, APIC, Belgium Francois Vandeweyer, Janssen Pharmaceutica NV.

Practical risk-based guide for managing data integrity Version 1, March 2019 . 2 ... impacting business decisions can be verified and inspected throughout the data lifecycle. ... a set of structured activities or tasks that produce a specific service for a particular customer or customers. It is often visualised as a flowchart of a sequence of ...

Tags:

  Customer, Lifecycle, Managing

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of Practical risk-based guide for managing data integrity

Related search queries